Updated: Oct 16, 2009
Irritant contact dermatitis (ICD) is inflammation of the skin typically manifested by erythema, mild edema, and scaling. Irritant contact dermatitis is a nonspecific response of the skin to direct chemical damage that releases mediators of inflammation predominately from epidermal cells. A corrosive agent causes the immediate death of epidermal cells as manifested by chemical burns and cutaneous ulcers.
Irritant contact dermatitis remains understudied compared to allergic contact dermatitis. Most articles on contact dermatitis concern allergic contact dermatitis. This largely reflects the fact that with patch testing, a specific hypersensitivity and a probable cause of dermatitis can be identified in most cases of allergic contact dermatitis. No diagnostic test exists for irritant contact dermatitis. The diagnosis rests on the exclusion of other cutaneous diseases (especially allergic contact dermatitis) and on the clinical appearance of dermatitis at a site sufficiently exposed to a known cutaneous irritant.
In the consumer world, the term hypoallergenic is used widely, although no Food and Drug Administration–approved definition of hypoallergenic exists. A necessity exists for hypoirritating cleansers, cosmetics, moisturizers, and protectants; however, no standard method exists to identify products that are of great use to individuals with susceptible skin (eg, atopic dermatitis, facial skin of individuals with rosacea).
The hands are the most important sites of irritant contact dermatitis. Most occupational skin disorders are irritant contact dermatitis resulting from repeated workplace exposure of the hands to soaps, cleansers, and solvents.
Irritant contact dermatitis is the clinical result of sufficient inflammation arising from the release of proinflammatory cytokines from skin cells (principally keratinocytes), usually in response to chemical stimuli. Different clinical forms may arise. The 3 main pathophysiological changes are skin barrier disruption, epidermal cellular changes, and cytokine release.
A wide range of chemicals with sufficient concentration or duration of exposures are capable of acting as cutaneous irritants. Common cutaneous irritants include detergent and water. Most cases of homemaker's eczema are irritant contact dermatitis resulting from repeated skin exposure to low-grade cutaneous irritants, particularly soaps, water, and detergents.
Cumulative irritant contact dermatitis from repeated mild skin irritation from soap and water is common. For example, hand-washing frequency of more than 35 times per shift was associated strongly with occupational hand dermatitis in intensive care unit workers (odds ratio = 4.13).
Solvents are another cause of cutaneous irritation because they remove essential fats and oils from the skin, which increases transepidermal water loss and renders the skin susceptible to the increased direct toxic effects of other previously well-tolerated cutaneous exposures. The alcohol propanol is less irritating to the skin than the detergent sodium lauryl sulfate.
p K a, an acid dissociation constant, is a quantitative measure of the strength of an acid in solution. p K a has been shown to be highly predictive of acute skin irritation for acids and bases; acids with a p K a of less than 4 and bases with a p K a of less than 8 are highly irritative.
1
Microtrauma also may produce skin irritation. A common example is fiberglass, which may produce pruritus with minimal visible inflammation in susceptible individuals. Many plant leaves and stems bear small spicules and barbs that produce direct skin trauma.
Physical irritants (eg, friction, abrasive grains, occlusion) and detergents such as sodium lauryl sulfate in combination produce more irritant contact dermatitis in combination than singly though propanol and sodium lauryl sulfate, are not additive irritants.
Skin irritation predisposes the skin to develop sensitization to topical agents. Skin irritation by both nonallergenic and allergenic compounds induces Langerhans cell migration and maturation.2 An exacerbation of irritant contact dermatitis may reflect development of allergic contact dermatitis to topical creams, medications, or rubber gloves.
The pathogenesis of irritant contact dermatitis involves resident epidermal cells, dermal fibroblasts, endothelial cells, and various leukocytes interacting with each other under the control of a network of cytokines and lipid mediators. Keratinocytes play an important role in the initiation and perpetuation of skin inflammatory reactions through the release of and responses to cytokines. Resting keratinocytes produce some cytokines constitutively.
A variety of environmental stimuli (eg, ultraviolet light, chemical agents) can induce epidermal keratinocytes to release inflammatory cytokines (interleukin 1, tumor necrosis factor-alpha), chemotactic cytokines (interleukin 8, interleukin 10), growth promoting cytokines (interleukin 6, interleukin 7, interleukin 15, granulocyte-macrophage colony-stimulating factor, transforming growth factor a), and cytokines regulating humoral versus cellular immunity (interleukin 10, interleukin 12, interleukin 18). Intercellular adhesion molecule 1 promotes the infiltration of leukocytes into the epidermis in cutaneous inflammatory reactions, including irritant contact dermatitis.
Significantly increased numbers of dividing keratinocytes are present 48 and 96 hours after exposure to the anionic emulsifying agent sodium lauryl sulfate (used in medicated shampoos, skin cleansers, acne treatments, and toothpastes and as an experimental irritant). At sites of previous irritant contact dermatitis chronic skin reactivity to sodium lauryl sulfate, hyperreactivity developed even after the 10th week postinduction compared with normal sites.3,4
All irritants provoke a similar pattern of cellular infiltration in the dermis; the densities of most of the cell types rise in proportion to the intensity of inflammation. Within the epidermis, marked differences exist in the patterns of cellular infiltration among different irritants.
Individuals with a past history of atopic dermatitis are prone to develop irritant contact dermatitis of the hands. Polymorphisms in the filaggrin (FLG) gene, which result in loss of filaggrin production, may alter the skin barrier and are a predisposing factor for atopic dermatitis. FLG null alleles are associated with increased susceptibility to chronic irritant contact dermatitis.5
Irritant contact dermatitis is common in occupations that involve repeated hand washing or repeated exposure of the skin to water, food materials, and other irritants. High-risk occupations include cleaning, hospital care, food preparation, and hairdressing. The prevalence of occupational hand dermatitis was found to be 55.6% in 2 intensive care units and was 69.7% in the most highly exposed workers (those reporting a frequency of hand washing >35 times per shift). Hand-washing frequency of more than 35 times per shift was associated strongly with occupational hand dermatitis.6
In Denmark, cleaners comprise the greatest number of affected workers, but culinary workers have the highest incidence. A higher proportion of prolonged sick leave is seen among those in food-related occupations compared with those in wet occupations.7 The incidence rates of irritant contact dermatitis and allergic contact dermatitis in Germany were 4.5 patients per 10,000 workers for irritant contact dermatitis, compared with 4.1 patients per 10,000 workers for allergic contact dermatitis. The highest irritant contact dermatitis annual incidence rates were found in hairdressers (46.9 cases per 10,000 workers per year), bakers (23.5 cases per 10,000 workers per year), and pastry cooks (16.9 cases per 10,000 workers per year.8
Hydrofluoric acid is a potent cutaneous irritant used in low-technology and high-technology industries and at home in rust removal.9 Exposure to this strong inorganic acid may produce death from hypocalcemia if as little as 1% of the skin's surface area is exposed sufficiently to this toxic agent and if complications are not managed optimally (see Hydrofluoric Acid Burns).
Irritant contact dermatitis is significantly more common in women than in men. The high frequency of hand eczema in women in comparison with men is caused by environmental factors, not genetic factors. Occupational irritant contact dermatitis affects women almost twice as often as men in contrast to other occupational diseases that predominantly affect men. Women are exposed more highly to cutaneous irritants from their disproportionately greater role in housecleaning and the care of small children at home. In addition, women predominantly perform many occupations at high risk for irritant contact dermatitis (eg, hairdressing, nursing).
Irritant contact dermatitis may occur at any age. Many cases of diaper dermatitis are irritant contact dermatitis resulting from direct skin irritants present in urine and, especially, feces. Older persons have drier and thinner skin that does not tolerate soaps and solvents as well as younger individuals. Occupational hand eczema often is associated with persistent dermatitis and prolonged sick leave with substantially greater severity among those with occupational irritant contact dermatitis and atopic dermatitis and age older than 50 years.
A detailed history is required because the diagnosis of irritant contact dermatitis rests on the history of exposure of the affected body site to the cutaneous irritant. Patch testing also is used in severe or persistent cases to exclude allergic contact dermatitis as a component of the individual's cutaneous manifestations.
Almost any material may be a cutaneous irritant with sufficient exposure in time and/or concentration.
| Asteatotic Eczema | Erythema Infectiosum (Fifth Disease) |
| Atopic Dermatitis | Erythrasma |
| Berloque Dermatitis | Id Reaction (Autoeczematization) |
| Candidiasis, Cutaneous | Intertrigo |
| Cellulitis | Jellyfish Stings |
| Chemical Peels | Lichen Simplex Chronicus |
| Complications of Dermatologic Laser
Surgery | Lupus Erythematosus, Acute |
| Contact Dermatitis, Allergic | Nummular Dermatitis |
| Cutaneous T-Cell Lymphoma | Onycholysis |
| Dermatologic Manifestations of Hematologic
Disease | Perioral Dermatitis |
| Dermatologic Manifestations of Renal
Disease | Phytophotodermatitis |
| Dermatomyositis | Pigmented Purpuric Dermatitis |
| Drug Eruptions | Pityriasis Alba |
| Drug-Induced Bullous Disorders | Seborrheic Dermatitis |
| Drug-Induced Photosensitivity | Stasis Dermatitis |
| Dyshidrotic Eczema | Tinea Cruris |
| Erysipelas |
The histopathology of acute experimental irritant contact dermatitis has been studied to a greater extent than chronic irritant contact dermatitis, which is the primary clinical complaint.
Cellular changes seen in the skin vary according to the chemical nature and concentration of the irritant applied, duration of exposure, severity of ensuing response, and time of sampling for acute irritant contact dermatitis. Many primary irritants cause overt necrosis if applied in a sufficiently high concentration for sufficient time.
Most histologic examinations of irritant contact dermatitis reveal some degree of intercellular edema or spongiosis in the epidermis. Spongiosis usually is less pronounced than that seen in allergic contact dermatitis reactions.
Parakeratosis also is observed widely in irritant contact dermatitis reactions.
The histology of chronic irritant contact dermatitis is one of hyperkeratosis with areas of parakeratosis, moderate-to-marked epidermal hyperplasia (acanthosis), and elongation of the rete ridges.
Acute irritant contact dermatitis reactions to potent irritants (eg, acids, alkaline solutions) are comparable to a chemical burn and can be graded like thermal burns (ie, first-, second-, or third-degree burns). With appropriate symptomatic management, the prognosis for this type of irritant contact dermatitis is usually good, and, unless the dermis is damaged, no permanent scarring should occur. See Burns, Chemical for more information.
An inflammatory reaction from acute delayed irritant contact dermatitis to an agent such as benzalkonium chloride (eg, zephiran) rarely needs treatment and usually resolves with cessation of exposure.
A clinical guideline summary from the American Academy of Allergy, Asthma and Immunology, Contact Dermatitis: A Practice Parameter, may be helpful.20
Activities of daily living and work may be reduced by severe irritant contact dermatitis.
Use of bland emollients, avoidance of irritation, and use of bland barrier creams such as those containing dimethicone are the mainstays of treatment for irritant contact dermatitis. A number of agents commonly found in therapeutic products for the skin (eg, propylene glycol, lactic acid, urea, salicylic acid) may produce further skin inflammation and may need to be avoided in these individuals. Topical corticosteroids play a limited role in the treatment of irritant contact dermatitis. They do not address the process directly, but they may be helpful for superimposed eczematous features.
Immunosuppressives with anti-inflammatory properties that modify the body's immune response to diverse stimuli. Other actions include vasoconstriction and antiproliferation. Have limited use in the treatment of irritant contact dermatitis.
Highly potent, fluorinated corticosteroid (class 2-3). Suppresses mitotic activity and causes vasoconstriction. Stimulates synthesis of enzymes needed to decrease inflammation. May suppress histamine release associated with pruritus.
Apply thin film up to tid
Not established
None reported
Documented hypersensitivity; fungal or viral infection, including herpes simplex or tubercular skin lesions; avoid application on face, groin, or axilla
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Systemic effects may occur if used over large areas, denuded areas of the body, or prolonged periods of time; occlusive dressing should not be used in presence of infection or weeping lesions; prolonged use may result in atrophy (especially in groin, axilla, and face), rosacealike eruption, striae distensae, or increased skin fragility
Fluorinated corticosteroid of mid potency with 0.025% (class 4-5) and mild potency with 0.01% (class 6).
Apply sparingly up to qid as severity warrants
Administer as in adults
None reported
Documented hypersensitivity; herpes simplex infection; fungal, viral, or tubercular skin lesions
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
May cause systemic effects if used over large areas, on denuded areas, or for prolonged periods; do not use occlusive dressing in presence of infection, in weeping lesions, or for ultrapotent corticosteroids; rarely, worsening or no improvement may signify allergy to corticosteroids
Watkins SA, Maibach HI. The hardening phenomenon in irritant contact dermatitis: an interpretative update. Contact Dermatitis. Mar 2009;60(3):123-30. [Medline].
Jacobs JJ, Lehe CL, Hasegawa H, Elliott GR, Das PK. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol. Jun 2006;15(6):432-40. [Medline].
Fluhr JW, Akengin A, Bornkessel A, et al. Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo. Br J Dermatol. Jul 2005;153(1):125-31. [Medline].
Heinemann C, Paschold C, Fluhr J, et al. Induction of a hardening phenomenon by repeated application of SLS: analysis of lipid changes in the stratum corneum. Acta Derm Venereol. 2005;85(4):290-5. [Medline].
de Jongh CM, Khrenova L, Verberk MM, Calkoen F, van Dijk FJ, Voss H, et al. Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. Br J Dermatol. Sep 2008;159(3):621-7. [Medline].
Forrester BG, Roth VS. Hand dermatitis in intensive care units. J Occup Environ Med. Oct 1998;40(10):881-5. [Medline].
Cvetkovski RS, Rothman KJ, Olsen J, et al. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol. Jan 2005;152(1):93-8. [Medline].
Dickel H, Kuss O, Schmidt A, Kretz J, Diepgen TL. Importance of irritant contact dermatitis in occupational skin disease. Am J Clin Dermatol. 2002;3(4):283-9. [Medline].
Mangion SM, Beulke SH, Braitberg G. Hydrofluoric acid burn from a household rust remover. Med J Aust. Sep 3 2001;175(5):270-1. [Medline].
Slotosch CM, Kampf G, Löffler H. Effects of disinfectants and detergents on skin irritation. Contact Dermatitis. Oct 2007;57(4):235-41. [Medline].
Rietschel RL, Fowler JF Jr. Fisher's Contact Dermatitis. 4th ed. Baltimore, Md: Lippincott Williams & Wilkins; 1995.
Kartono F, Maibach HI. Irritants in combination with a synergistic or additive effect on the skin response: an overview of tandem irritation studies. Contact Dermatitis. Jun 2006;54(6):303-12. [Medline].
Löffler H, Kampf G, Schmermund D, Maibach HI. How irritant is alcohol?. Br J Dermatol. Jul 2007;157(1):74-81. [Medline].
Weston WL, Morelli JG. Dermatitis under soccer shin guards: allergy or contact irritant reaction?. Pediatr Dermatol. Jan-Feb 2006;23(1):19-20. [Medline].
Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006;19(6):296-302. [Medline].
[Guideline] Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Part 1. National Guideline Clearinghouse. Mar 2008.
[Guideline] Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Part 2. National Guideline Clearinghouse. Mar 2008.
Levin C, Zhai H, Bashir S, et al. Efficacy of corticosteroids in acute experimental irritant contact dermatitis?. Skin Res Technol. Nov 2001;7(4):214-8. [Medline].
Fuchs M, Schliemann-Willers S, Heinemann C, Elsner P. Tacrolimus enhances irritation in a 5-day human irritancy in vivo model. Contact Dermatitis. May 2002;46(5):290-4. [Medline].
[Guideline] American Academy of Allergy, Asthma and Immunology. Contact dermatitis: a practice parameter. Ann Allergy Asthma Immunol. Sep 2006;97(3 Suppl 2):S1-38. [Medline].
Lakshmi C, Srinivas CR, Anand CV, Mathew AC. Irritancy ranking of 31 cleansers in the Indian market in a 24-h patch test. Int J Cosmet Sci. Aug 2008;30(4):277-83. [Medline].
Baranda L, Gonzalez-Amaro R, Torres-Alvarez B, Alvarez C, Ramirez V. Correlation between pH and irritant effect of cleansers marketed for dry skin. Int J Dermatol. Aug 2002;41(8):494-9. [Medline].
Beltrani VS. Occupational dermatoses. Curr Opin Allergy Clin Immunol. Apr 2003;3(2):115-23. [Medline].
Bryld LE, Hindsberger C, Kyvik KO, Agner T, Menne T. Risk factors influencing the development of hand eczema in a population-based twin sample. Br J Dermatol. Dec 2003;149(6):1214-20. [Medline].
Choi JM, Lee JY, Cho BK. Chronic irritant contact dermatitis: recovery time in man. Contact Dermatitis. May 2000;42(5):264-9. [Medline].
Frosch PJ, Menne T, Lepoittevin J-P, eds. Contact Dermatitis. 4th. Berlin, Germany: Springer; 2006.
Goldner R. Work-related irritant contact dermatitis. Occup Med. Jan-Mar 1994;9(1):37-44. [Medline].
Hogan DJ. The prognosis of occupational contact dermatitis. Occup Med. Jan-Mar 1994;9(1):53-8. [Medline].
Hogan DJ, Dannaker CJ, Maibach HI. The prognosis of contact dermatitis. J Am Acad Dermatol. Aug 1990;23(2 Pt 1):300-7. [Medline].
Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev. Oct 2004;17(4):863-93, table of contents. [Medline].
Kligman AM. The identification of contact allergens by human assay. 3. The maximization test: a procedure for screening and rating contact sensitizers. J Invest Dermatol. Nov 1966;47(5):393-409. [Medline].
McFadden JP, Basketter DA. Contact allergy, irritancy and 'danger'. Contact Dermatitis. Mar 2000;42(3):123-7. [Medline].
Rietschel RL, Nethercott JR, Emmett EA, et al. Methylchloroisothiazolinone-methylisothiazolinone reactions in patients screened for vehicle and preservative hypersensitivity. J Am Acad Dermatol. May 1990;22(5 Pt 1):734-8. [Medline].
Smith HR, Basketter DA, McFadden JP. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol. Mar 2002;27(2):138-46. [Medline].
Willis CM, Reiche L, Wilkinson JD. Immunocytochemical demonstration of reduced Cu,Zn-superoxide dismutase levels following topical application of dithranol and sodium lauryl sulphate: an indication of the role of oxidative stress in acute irritant contact dermatitis. Eur J Dermatol. Jan-Feb 1998;8(1):8-12. [Medline].
Willis CM, Reiche L, Wilkinson JD. Keratin 17 is expressed during the course of SLS-induced irritant contact dermatitis, but unlike keratin 16, the degree of expression is unrelated to the density of dividing keratinocytes. Contact Dermatitis. Jul 1998;39(1):21-7. [Medline].
Willis CM, Stephens CJ, Wilkinson JD. Differential patterns of epidermal leukocyte infiltration in patch test reactions to structurally unrelated chemical irritants. J Invest Dermatol. Sep 1993;101(3):364-70. [Medline].
Willis CM, Stephens CJ, Wilkinson JD. Selective expression of immune-associated surface antigens by keratinocytes in irritant contact dermatitis. J Invest Dermatol. Apr 1991;96(4):505-11. [Medline].
Willis CM, Young E, Brandon DR, Wilkinson JD. Immunopathological and ultrastructural findings in human allergic and irritant contact dermatitis. Br J Dermatol. Sep 1986;115(3):305-16. [Medline].
irritant contact dermatitis, contact dermatitis, nonallergic contact dermatitis, ICD
Daniel J Hogan, MD, Clinical Professor of Internal Medicine (Dermatology), NOVA Southeastern University; Investigator, Hill Top Research, Florida Research Center
Daniel J Hogan, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, and Canadian Dermatology Association
Disclosure: Nothing to disclose.
John D Wilkinson, MD, MBBS, MRCS, FRCP, Chairman, Clinical Director, Department of Dermatology, Amersham Hospital and High Wycombe Hospital, UK
John D Wilkinson, MD, MBBS, MRCS, FRCP is a member of the following medical societies: American Academy of Dermatology and Royal College of Physicians
Disclosure: Nothing to disclose.
Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.
Paul Krusinski, MD, Director of Dermatology, Professor, Department of Internal Medicine, Fletcher Allen Health Care, University of Vermont
Paul Krusinski, MD is a member of the following medical societies: American Academy of Dermatology, American College of Physicians, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.
Catherine M Quirk, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania
Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.
Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)